Edge Article
Chemical Science
and C. M. Crudden, Chem. Sci., 2021, DOI: 10.1039/
D1SC00133G.
Conclusions
2 (a) G. A. Patani and E. J. LaVoie, Chem. Rev., 1996, 96, 3147–
3176; (b) Metabolism, Pharmacokinetics and Toxicity of
Functional Groups, ed. D. A. Smith, Royal Society of
Chemistry: London, United Kingdom, 2010, pp. 99–167,
210–274; (c) E. A. Ilardi, E. Vitaku and J. T. Njardarson, J.
Med. Chem., 2014, 57, 2832–2842; (d) K. A. Scott and
J. T. Njardarson, Top. Curr. Chem., 2018, 376, 5.
3 H. L. Friedman, Inuence of isosteric replacements upon
biological activity, NAS-NRS, Washington, DC, 1951, vol.
206, pp. 295–358, NAS-NRS Publication No. 206.
In conclusion, we have developed a visible light-induced pho-
tocatalytic amidosulfonation platform that enables the rst
direct conversion of a wide range of carboxylic acids to aliphatic
and aromatic sulfonamides, as well as sulfonyl azides in an
adaptive tricomponent process with electrophilic and nucleo-
philic N-centered coupling partners. The scope and functional
group tolerance of the method were further demonstrated on
representative functionalized substrates, as well as natural
products and medicinally relevant compounds. The develop-
ment of the dual catalytic process for concomitant formation of
C–S and C–N bonds with electrophilic and nucleophilic
nitrogen coupling partners points to a potential adaptability of
the photocatalytic platform to a wide range of sulfonyl products.
4 For
examples
of
non-decarboxylative
one-step
intermolecular tricomponent approaches to aromatic
sulfonamides, see: (a) B. Nguyen, E. J. Emmett and
M. C. Willis, J. Am. Chem. Soc., 2010, 132, 16372–16373; (b)
A. S. Tsai, J. M. Curto, B. N. Rocke, A. M. R. Dechert-
Schmitt, G. K. Ingle and V. Mascitti, Org. Lett., 2016, 18,
508–511; (c) N. -W. Liu, S. Liang and G. Manolikakes, Adv.
Synth. Catal., 2017, 359, 1308–1319; (d) Y. Chen,
P. R. Murray, A. T. Davies and M. C. Willis, J. Am. Chem.
Soc., 2018, 140, 8781–8787; (e) F. Zhang, D. Zheng, L. Lai,
J. Cheng, J. Sun and J. Wu, Org. Lett., 2018, 20, 1167–1170;
Author contributions
OVL conceived the project. VTN, VDN, and NTHV carried out
the experiments and GCH performed the computational
studies, in consultation with OVL. HDA performed the X-ray
crystallography studies. OVL, wrote the manuscript, and VTN,
VDN, NTHV, and GCH contributed to writing the manuscript.
´
(f) X. Marset, J. Torregrosa-Crespo, R. M. Martınez-
´
Espinosa, G. Guillena and D. J. Ramon, Green Chem., 2019,
Conflicts of interest
21, 4127–4132; (g) X. Wang, M. Yang, Y. Kuang, J.-B. Liu,
X. Fan and J. Wu, Chem. Commun., 2020, 56, 3437–3440; (h)
S. P. Blum, T. Karakaya, D. Schollmeyer, A. Klapars and
S. R. Waldvogel, Angew. Chem., Int. Ed., 2021, 60, 5056–
5062For examples of stepwise and one-pot approaches, see:
(i) A. Shavnya, S. B. Coffey, K. D. Hesp, S. C. Ross and
A. S. Tsai, Org. Lett., 2016, 18, 5848–5851; (j) Y.-Y. Jiang,
Q.-Q. Wang, S. Liang, L.-M. Hu, R. D. Little and C.-C. Zeng,
J. Org. Chem., 2016, 81, 4713–4719; (k) D.-K. Kim, H.-S. Um,
H. Park, S. Kim, J. Choi and C. Lee, Chem. Sci., 2020, 11,
13071–13078For examples of other C–S bond forming
approaches to sulfonamides, see: (l) S. M. Hell,
There are no conicts to declare.
Acknowledgements
Financial support by NIGMS (GM134371) is gratefully
acknowledged. The UTSA NMR and X-ray crystallography facil-
ities were supported by NSF (CHE-1625963 and CHE-1920057).
The authors acknowledge the Texas Advanced Computing
Center (TACC) for providing computational resources.
Notes and references
¨
C. F. Meyer, G. Laudadio, A. Misale, M. C. Willis, T. Noel,
1 (a) The Chemistry of Sulphinic Acids, Esters and their
Derivatives, ed. S. Patai, John Wiley & Sons, Ltd, New Jersey,
1990; (b) The Chemistry of Sulphonic Acids, Esters and their
Derivatives, ed. S. Patai and Z. Rapport, John Wiley & Sons,
A. A. Trabanco and V. Gouverneur, J. Am. Chem. Soc., 2020,
142, 720–725; (m) T. Q. Davies, M. J. Tilby, D. Skolc, A. Hall
and M. C. Willis, Org. Lett., 2020, 22, 9495–9499For
examples of intermolecular tricomponent syntheses of
aliphatic N-aminosulfonamides, see: (n) Y. Li, D. Zheng,
Z. Li and J. Wu, Org. Chem. Front., 2016, 3, 574–578; (o)
K. Zhou, H. Xia and J. Wu, Org. Chem. Front., 2016, 3, 865–
869For other recent approaches to sulfonamides that do
not involve C–S bond formation, see: (p) E. Hayashi,
Y. Yamaguchi, Y. Kita, K. Kamata and M. Hara, Chem.
Commun., 2020, 56, 2095–2098; (q) G. Laudadio,
E. Barmpoutsis, C. Schotten, L. Struik, S. Govaerts,
´
New York, 1991; (c) X. Zhao, E. Dimitrijevic and
V. M. Dong, J. Am. Chem. Soc., 2009, 131, 3466–3467; (d)
P. K. Dornan, K. G. M. Kou, K. N. Houk and V. M. Dong, J.
´
´
Am. Chem. Soc., 2014, 136, 291; (e) A. Garcıa-Domınguez,
¨
S. Muller and C. Nevado, Angew. Chem., Int. Ed., 2017, 56,
9949–9952; (f) E. G. Burke, B. Gold, T. T. Hoang,
R. T. Raines and J. M. Schomaker, J. Am. Chem. Soc., 2017,
139, 8029–8037; (g) V. T. Nguyen, H. T. Dang, H. H. Pham,
V. D. Nguyen, C. Flores-Hansen, H. D. Arman and
O. V. Larionov, J. Am. Chem. Soc., 2018, 140, 8434–8438; (h)
M. Ratushnyy, M. Kamenova and V. Gevorgyan, Chem. Sci.,
2018, 9, 7193–7197; (i) S. M. Hell, C. F. Meyer, A. Misale,
J. B. I. Sap, K. K. Christensen, M. C. Willis, A. A. Trabanco
and V. Gouverneur, Angew. Chem., Int. Ed., 2020, 59, 11620–
11626; (j) M. Nambo, Y. Tahara, J. C.-H. Yim, D. Yokogawa
¨
D. L. Browne and T. Noel, J. Am. Chem. Soc., 2019, 141,
5664–5668; (r) A. Tota, S. St John-Campbell, E. L. Briggs,
G. O. Estevez, M. Afonso, L. Degennaro, R. Luisi and
J. A. Bull, Org. Lett., 2018, 20, 2599–2602.
5 (a) Bioactive Carboxylic Compound Classes: Pharmaceuticals
and Agrochemicals, ed. C. Lamberth and J. Dinges, Wiley,
´
2016; (b) J. Iglesias, I. Martınez-Salazar, P. Maireles-Torres,
© 2021 The Author(s). Published by the Royal Society of Chemistry
Chem. Sci., 2021, 12, 6429–6436 | 6435